Ammirati, Enrico https://orcid.org/0000-0002-1676-5257
Buono, Andrea
Moroni, Francesco
Gigli, Lorenzo
Power, John R.
Ciabatti, Michele
Garascia, Andrea
Adler, Eric D.
Pieroni, Maurizio
Funding for this research was provided by:
Italian Ministry of Health (GR-2019-12368506)
Article History
Accepted: 10 February 2022
First Online: 24 February 2022
Compliance with Ethical Standards
:
: E.D. Adler is a consultant for Abbott, Abiomed, AstraZenica, Endotronix, Ionis, Medtronic, and Novartis, and is on the board of directors of Genstem Therapeutics and shareholder of Rocket Pharmaceuticals. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.